US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ORUKA THERAPEUTICS INC

25.51

+1.024.14%

Post-market: 26.000.4950+1.94%19:42 EDT

Volume:538.08K

Turnover:13.58M

Market Cap:1.23B

PE:-11.90

High:26.19

Open:25.36

Low:24.46

Close:24.49

52wk High:31.13

52wk Low:5.49

Shares:48.38M

Float Shares:22.41M

Volume Ratio:0.91

T/O Rate:2.40%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1429

EPS(LYR):-3.8737

ROE:--

ROA:--

PB:3.62

PE(LYR):-6.58

Loading ...

Overview Company News Filings

Major Issues Report

Form 8-K - Current report

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Major Issues Report

Form 8-K - Current report

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Business Combinations

Form 425 - Prospectuses and communications, business combinations

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Business Combinations

Form 425 - Prospectuses and communications, business combinations

Major Issues Report

Form 8-K - Current report

Business Combinations

Form 425 - Prospectuses and communications, business combinations

Business Combinations

Form 425 - Prospectuses and communications, business combinations

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Business Combinations

Form 425 - Prospectuses and communications, business combinations

Major Issues Report

Form 8-K - Current report

Correspondence

Form CORRESP - Correspondence

Correspondence

Form CORRESP - Correspondence

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ORKA/filings?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ORKA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","market":"US","secType":"STK","nameCN":"ORUKA THERAPEUTICS INC","latestPrice":25.505,"timestamp":1760385600000,"preClose":24.49,"halted":0,"volume":538080,"hourTrading":{"tag":"盘后","latestPrice":26,"preClose":25.505,"latestTime":"19:42 EDT","volume":2768,"amount":70692.875,"timestamp":1760398945698},"delay":0,"floatShares":22408091,"shares":48384150,"eps":-2.142931,"marketStatus":"Not Yet Opened","change":1.015,"latestTime":"10-13 16:00:00 EDT","open":25.36,"high":26.185,"low":24.46,"amount":13582316.51904,"amplitude":0.070437,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.142931,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760428800000},"marketStatusCode":0,"adr":0,"listingDate":871012800000,"exchange":"NASDAQ","adjPreClose":24.49,"preHourTrading":{"tag":"盘前","latestPrice":26.9,"preClose":24.49,"latestTime":"09:25 EDT","volume":27,"amount":697.550022,"timestamp":1760361909057},"postHourTrading":{"tag":"盘后","latestPrice":26,"preClose":25.505,"latestTime":"19:42 EDT","volume":2768,"amount":70692.875,"timestamp":1760398945698},"volumeRatio":0.907718,"impliedVol":0.8763,"impliedVolPercentile":0.5912},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","floatShares":22408091,"roa":"--","roe":"--","lyrEps":-3.873702,"volumeRatio":0.907718,"shares":48384150,"dividePrice":0,"high":26.185,"amplitude":0.070437,"preClose":24.49,"low":24.46,"week52Low":5.485,"pbRate":"3.62","week52High":31.13,"institutionHeld":0.9835,"latestPrice":25.505,"eps":-2.142931,"divideRate":0,"volume":538080,"delay":0,"ttmEps":-2.142931,"open":25.36,"prevYearClose":19.39,"prevWeekClose":24.49,"prevMonthClose":19.23,"prevQuarterClose":19.23,"fiveDayClose":20.33,"twentyDayClose":15.26,"sixtyDayClose":14.54},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ORKA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-03","symbol":"ORKA","defaultRemindTime":1725370200000,"type":"split","dateTimestamp":1725336000000,"forFactor":12,"toFactor":1,"ratio":12},{"date":"2024-08-29","symbol":"ORKA","amount":1.613,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-26","defaultRemindTime":1724938200000,"name":"方舟生物医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-28","payableDate":"2024-08-26","currency":"USD","dateTimestamp":1724904000000,"payDate":"2024-08-28"},{"market":"US","date":"2024-08-01","symbol":"ORKA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2024-04-25","symbol":"ORKA","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2024-02-01","symbol":"ORKA","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1706763600000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ORKA\",market:\"US\",,,undefined,":[{"executeDate":"2024-08-29","recordDate":"2024-08-26","paymentDate":"2024-08-28","value":1.613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ORKA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":10,"updateTime":1755921600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ORKA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ORKA","date":"2025-10-10","current":-11.901923,"percent":0,"low":-11.49024,"twenty":-5.309118,"median":-4.714571,"eighty":-3.994896,"high":-2.779284,"avg":-4.746632,"sd":1.011255,"marketCap":1236215032},"quantilePoints":[{"date":"2025-03-14","current":-4.566552,"twenty":-4.600166,"median":-4.533759,"eighty":-4.155287,"marketCap":417087281},{"date":"2025-03-21","current":-4.898591,"twenty":-4.788731,"median":-4.634189,"eighty":-4.465422,"marketCap":447414094},{"date":"2025-03-28","current":-4.898591,"twenty":-4.90187,"median":-4.734621,"eighty":-4.543597,"marketCap":447414094},{"date":"2025-04-04","current":-3.656521,"twenty":-4.90187,"median":-4.68543,"eighty":-4.155287,"marketCap":333969349},{"date":"2025-04-11","current":-3.021139,"twenty":-4.898591,"median":-4.546056,"eighty":-3.567158,"marketCap":275936558},{"date":"2025-04-17","current":-3.529445,"twenty":-4.883833,"median":-4.205819,"eighty":-3.28595,"marketCap":322362791},{"date":"2025-04-25","current":-4.304201,"twenty":-4.810047,"median":-4.25501,"eighty":-3.440082,"marketCap":393125355},{"date":"2025-05-02","current":-4.136132,"twenty":-4.747739,"median":-4.214018,"eighty":-3.521247,"marketCap":377774745},{"date":"2025-05-09","current":-3.996758,"twenty":-4.714945,"median":-4.198946,"eighty":-3.605691,"marketCap":365044972},{"date":"2025-05-16","current":-3.364967,"twenty":-4.682151,"median":-4.136132,"eighty":-3.605691,"marketCap":354187224},{"date":"2025-05-23","current":-3.980336,"twenty":-4.607544,"median":-4.002451,"eighty":-3.625269,"marketCap":418959306},{"date":"2025-05-30","current":-4.215101,"twenty":-4.558354,"median":-4.038702,"eighty":-3.660839,"marketCap":443670043},{"date":"2025-06-06","current":-4.336041,"twenty":-4.541137,"median":-4.079934,"eighty":-3.705732,"marketCap":456399816},{"date":"2025-06-13","current":-4.57792,"twenty":-4.558354,"median":-4.136132,"eighty":-3.769048,"marketCap":481859363},{"date":"2025-06-20","current":-4.261343,"twenty":-4.543597,"median":-4.170639,"eighty":-3.777968,"marketCap":448537309},{"date":"2025-06-27","current":-4.136846,"twenty":-4.523383,"median":-4.154632,"eighty":-3.785238,"marketCap":435433131},{"date":"2025-07-03","current":-4.48188,"twenty":-4.48188,"median":-4.154632,"eighty":-3.808193,"marketCap":471750426},{"date":"2025-07-11","current":-5.004766,"twenty":-4.566552,"median":-4.184867,"eighty":-3.812292,"marketCap":526787975},{"date":"2025-07-18","current":-5.463625,"twenty":-4.701827,"median":-4.197316,"eighty":-3.861483,"marketCap":575086233},{"date":"2025-07-25","current":-5.061679,"twenty":-4.767415,"median":-4.21456,"eighty":-3.877182,"marketCap":532778457},{"date":"2025-08-01","current":-4.834028,"twenty":-4.898055,"median":-4.257786,"eighty":-3.894967,"marketCap":508816530},{"date":"2025-08-08","current":-4.862484,"twenty":-4.898591,"median":-4.281656,"eighty":-3.898524,"marketCap":511811771},{"date":"2025-08-15","current":-5.221398,"twenty":-4.905169,"median":-4.336041,"eighty":-3.910674,"marketCap":561761175},{"date":"2025-08-22","current":-5.148299,"twenty":-5.001209,"median":-4.36364,"eighty":-3.910674,"marketCap":553896518},{"date":"2025-08-29","current":-5.315383,"twenty":-5.050833,"median":-4.460538,"eighty":-3.918873,"marketCap":571872876},{"date":"2025-09-05","current":-5.210955,"twenty":-5.062675,"median":-4.474766,"eighty":-3.936742,"marketCap":560637652},{"date":"2025-09-12","current":-5.621705,"twenty":-5.07235,"median":-4.48188,"eighty":-3.943016,"marketCap":604829531},{"date":"2025-09-19","current":-5.771385,"twenty":-5.152476,"median":-4.546056,"eighty":-3.972962,"marketCap":620933352},{"date":"2025-09-26","current":-5.238803,"twenty":-5.191462,"median":-4.609934,"eighty":-3.980356,"marketCap":563633712},{"date":"2025-10-03","current":-6.676428,"twenty":-5.243928,"median":-4.669033,"eighty":-3.986032,"marketCap":718305289},{"date":"2025-10-10","current":-11.49024,"twenty":-5.309118,"median":-4.714571,"eighty":-3.994896,"marketCap":1236215032}],"updateTime":1760423670629},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"ORKA\",pageSize:20,pageCount:2,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"18680471","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024085543-ORKA","pdf_url":"","pub_time":1728014400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ORKA","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/907654/000121390024085543/0001213900-24-085543-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDED AND RESTATED EMPLOYMENT LETTER AGREEMENT BY AND BETWEEN THE COMPANY AND","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024085543/ea021674601ex10-1_oruka.htm","primary":true,"translateUrl":"","linkName":"ea021674601ex10-1_oruka.htm","type":"EX-10.1","id":"NTFILEEXBFD9thnRkVq5ZJ","market":"us","size":63639},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024085543/ea0216746-8k_oruka.htm","primary":false,"translateUrl":"","linkName":"ea0216746-8k_oruka.htm","type":"8-K","id":"NTFILEHvCGfQVH6mxbFz2D","market":"us","size":30564},{"description":"AMENDED AND RESTATED EMPLOYMENT LETTER AGREEMENT BY AND BETWEEN THE COMPANY AND","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024085543/ea021674601ex10-2_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021674601ex10-2_oruka.htm","type":"EX-10.2","id":"NTFILECbVUcVxkXnAEmKuK","market":"us","size":58195},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024085543/ex10-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex10-1_001.jpg","type":"GRAPHIC","id":"NTFILEGA6dmxM4YdUMVK5i","market":"us","size":6156},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024085543/ex10-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex10-2_001.jpg","type":"GRAPHIC","id":"NTFILEGb95RRDbdcWPBrvB","market":"us","size":6156}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2024-10-04 12:00","pubTimestamp":1728014400,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18615592","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024078635-ORKA","pdf_url":"","pub_time":1726261020000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","symbol":"ORKA","title":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/907654/0001213900-24-078635-index.html","us_notice_code":"Form SC 13D/A","us_title_en":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024078635/ea0214512-13da1fair_oruka.htm","primary":true,"translateUrl":"","linkName":"ea0214512-13da1fair_oruka.htm","type":"SC 13D/A","id":"NTFILE7i1vBzBTdFsbEbVB","market":"us","size":131942}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2024-09-14 04:57","pubTimestamp":1726261020,"title_zh":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18615593","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024078549-ORKA","pdf_url":"","pub_time":1726257759000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ORKA","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/907654/0001213900-24-078549-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A NO","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024078549/ea021443901ex3-1_oruka.htm","primary":true,"translateUrl":"","linkName":"ea021443901ex3-1_oruka.htm","type":"EX-3.1","id":"NTFILE5sYRY92mgAeDekF2","market":"us","size":99519},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024078549/ea0214439-8k_oruka.htm","primary":false,"translateUrl":"","linkName":"ea0214439-8k_oruka.htm","type":"8-K","id":"NTFILE5XieScabxYp8xy4Z","market":"us","size":65867},{"description":"FORM OF PRE-FUNDED WARRANT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024078549/ea021443901ex4-1_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021443901ex4-1_oruka.htm","type":"EX-4.1","id":"NTFILEFCPfBGYi5sX6p6ih","market":"us","size":76835},{"description":"SECURITIES PURCHASE AGREEMENT, DATED SEPTEMBER 11, 2024, BY AND BETWEEN ORUKA TH","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024078549/ea021443901ex10-1_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021443901ex10-1_oruka.htm","type":"EX-10.1","id":"NTFILE4oMkPGP1KDxbiagD","market":"us","size":410039},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024078549/ea021443901ex10-2_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021443901ex10-2_oruka.htm","type":"EX-10.2","id":"NTFILEAi5xABZpcZUyZqdy","market":"us","size":109980},{"description":"PRESS RELEASE, DATED SEPTEMBER 11, 2024","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024078549/ea021443901ex99-1_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021443901ex99-1_oruka.htm","type":"EX-99.1","id":"NTFILE7aJmU7XCtbbtq71R","market":"us","size":15032},{"description":"PRESS RELEASE, DATED SEPTEMBER 11, 2024","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024078549/ea021443901ex99-2_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021443901ex99-2_oruka.htm","type":"EX-99.2","id":"NTFILE7dz2Qa7iyY3VcDyc","market":"us","size":12896},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024078549/ex99-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE7PjHz3rNekowGWMR","market":"us","size":10009}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2024-09-14 04:02","pubTimestamp":1726257759,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18593610","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024076599-ORKA","pdf_url":"","pub_time":1725656929000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D - General Statement of Acquisition of Beneficial Ownership","symbol":"ORKA","title":"Form SC 13D - General Statement of Acquisition of Beneficial Ownership","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/907654/0001213900-24-076599-index.html","us_notice_code":"Form SC 13D","us_title_en":"Form SC 13D - General Statement of Acquisition of Beneficial Ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076599/ea0213742-13dfair_oruka.htm","primary":true,"translateUrl":"","linkName":"ea0213742-13dfair_oruka.htm","type":"SC 13D","id":"NTFILET21BRE7ePcsGBQK2","market":"us","size":142353},{"description":"JOINT FILING AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076599/ea021374201ex99-1_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021374201ex99-1_oruka.htm","type":"EX-99.1","id":"NTFILEEVh92H3Nm72V6BRN","market":"us","size":8162},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT, BY AND AMONG THE COMPANY, PRE-MERGER ORUK","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076599/ea021374201ex99-4_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021374201ex99-4_oruka.htm","type":"EX-99.4","id":"NTFILE6yYrtKnoGQzmwCuF","market":"us","size":108139}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2024-09-07 05:08","pubTimestamp":1725656929,"title_zh":"Form SC 13D - General Statement of Acquisition of Beneficial Ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18635240","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024076184-ORKA","pdf_url":"","pub_time":1725508800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ORKA","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/0001213900-24-076184-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.01: Completion of Acquisition or Disposition of Assets;\nItem 2.02: Results of Operations and Financial Condition;\nItem 3.03: Material Modifications to Rights of Security Holders;\nItem 4.01: Changes in Registrant's Certifying Accountant;\nItem 5.01: Changes in Control of Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics;\nItem 5.06: Change in Shell Company Status;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex3-1_oruka.htm","primary":true,"translateUrl":"","linkName":"ea021319301ex3-1_oruka.htm","type":"EX-3.1","id":"NTFILEjA2tmYaBxegpw2UL","market":"us","size":7601},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea0213193-8k_orukathera.htm","primary":false,"translateUrl":"","linkName":"ea0213193-8k_orukathera.htm","type":"8-K","id":"NTFILEBZYi8N1YZHkgZVVq","market":"us","size":297575},{"description":"CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex3-2_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex3-2_oruka.htm","type":"EX-3.2","id":"NTFILEHxHmR6HZcE8miFrf","market":"us","size":7602},{"description":"CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex3-3_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex3-3_oruka.htm","type":"EX-3.3","id":"NTFILECUGA2ZkZPxmiC6Ps","market":"us","size":6489},{"description":"CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex3-4_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex3-4_oruka.htm","type":"EX-3.4","id":"NTFILEFd6SVrAwJCRmYMT1","market":"us","size":8875},{"description":"AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE COMPANY, FILED SEPTEMBE","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex3-5_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex3-5_oruka.htm","type":"EX-3.5","id":"NTFILE8RdqeSdvBZ815XU1","market":"us","size":26746},{"description":"AMENDED AND RESTATED BYLAWS OF THE COMPANY","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex3-6_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex3-6_oruka.htm","type":"EX-3.6","id":"NTFILEFvah6xPKa1vktp4v","market":"us","size":152087},{"description":"FORM OF CERTIFICATE OF ELIMINATION OF CERTIFICATE OF DESIGNATION OF PREFERENCES,","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex3-8_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex3-8_oruka.htm","type":"EX-3.8","id":"NTFILEB7k9Jh4xF7dPVgqT","market":"us","size":9386},{"description":"FORM OF CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SER","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex3-9_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex3-9_oruka.htm","type":"EX-3.9","id":"NTFILE55YADS5XWJqK23TL","market":"us","size":71073},{"description":"ORUKA THERAPEUTICS, INC. 2024 STOCK INCENTIVE PLAN","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex10-10_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex10-10_oruka.htm","type":"EX-10.10","id":"NTFILEHASvdSm28UFWYBkB","market":"us","size":113469},{"description":"ORUKA THERAPEUTICS, INC. 2024 EMPLOYEE STOCK PURCHASE PLAN","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex10-11_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex10-11_oruka.htm","type":"EX-10.11","id":"NTFILECi3YaujPtGYTFMF6","market":"us","size":82081},{"description":"SECOND AMENDMENT TO AMENDED AND RESTATED ORUKA THERAPEUTICS, INC. 2024 EQUITY IN","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex10-13_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex10-13_oruka.htm","type":"EX-10.13","id":"NTFILEEC6qLJ9KXYcNK159","market":"us","size":11652},{"description":"FORM OF EMPLOYEE WARRANT AGREEMENT","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex10-16_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex10-16_oruka.htm","type":"EX-10.16","id":"NTFILE9N3GBUq985eGLAsa","market":"us","size":34388},{"description":"CONSULTING AGREEMENT, EFFECTIVE AS OF AUGUST 30, 2024, BY AND BETWEEN ORUKA THER","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex10-25_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex10-25_oruka.htm","type":"EX-10.25","id":"NTFILE3FJLPncHbaV6u41y","market":"us","size":76344},{"description":"CODE OF BUSINESS CONDUCT AND ETHICS OF ORUKA THERAPEUTICS, INC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex14-1_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex14-1_oruka.htm","type":"EX-14.1","id":"NTFILE3Ez8vr8KbhEAJK8B","market":"us","size":86667},{"description":"LETTER FROM KPMG LLP, DATED SEPTEMBER 5, 2024","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex16-1_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex16-1_oruka.htm","type":"EX-16.1","id":"NTFILEHGBbmj5hX3kaNFFw","market":"us","size":2741},{"description":"LIST OF SUBSIDIARIES OF ORUKA THERAPEUTICS, INC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex21-1_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex21-1_oruka.htm","type":"EX-21.1","id":"NTFILE3iCGKm1iwfhAcrd9","market":"us","size":2260},{"description":"PRESS RELEASE, ISSUED ON SEPTEMBER 3, 2024","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex99-1_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex99-1_oruka.htm","type":"EX-99.1","id":"NTFILEE4hnsSeJXVcbN2Nm","market":"us","size":12993},{"description":"AUDITED FINANCIAL STATEMENT OF ORUKA THERAPEUTICS, INC. AS OF FEBRUARY 6, 2024","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex99-2_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex99-2_oruka.htm","type":"EX-99.2","id":"NTFILE86NVvhMWZQ4r51xg","market":"us","size":52736},{"description":"UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF ORUKA THERAPEUT","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex99-3_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex99-3_oruka.htm","type":"EX-99.3","id":"NTFILE13boMhp79Ky3ptBw","market":"us","size":231546},{"description":"MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex99-4_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex99-4_oruka.htm","type":"EX-99.4","id":"NTFILE5mr9jpBPFuVqy3cz","market":"us","size":150801},{"description":"UNAUDITED PRO FORMA FINANCIAL STATEMENTS OF ORUKA THERAPEUTICS, INC. AND ARCA BI","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ea021319301ex99-5_oruka.htm","primary":false,"translateUrl":"","linkName":"ea021319301ex99-5_oruka.htm","type":"EX-99.5","id":"NTFILE6PGaHygUdWjGtVLq","market":"us","size":244728},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024076184/ex14-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex14-1_001.jpg","type":"GRAPHIC","id":"NTFILEBnfVyWBHP129XA6R","market":"us","size":6156}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2024-09-05 12:00","pubTimestamp":1725508800,"title_zh":"Form 8-K - Current report","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18635206","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024072683-ORKA","pdf_url":"","pub_time":1724731200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ORKA","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/907654/000121390024072683/0001213900-24-072683-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE, ISSUED ON AUGUST 26, 2024","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024072683/ea021246201ex99-1_arcabio.htm","primary":true,"translateUrl":"","linkName":"ea021246201ex99-1_arcabio.htm","type":"EX-99.1","id":"NTFILE8YzuywTUi7x5xpZG","market":"us","size":18615},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024072683/ea0212462-8k425_arcabio.htm","primary":false,"translateUrl":"","linkName":"ea0212462-8k425_arcabio.htm","type":"8-K","id":"NTFILEGPxeqjmxS3UzgPZc","market":"us","size":38376}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2024-08-27 12:00","pubTimestamp":1724731200,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18635188","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024072685-ORKA","pdf_url":"","pub_time":1724731200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 425 - Prospectuses and communications, business combinations","symbol":"ORKA","title":"Form 425 - Prospectuses and communications, business combinations","titleType":"Business Combinations","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/907654/000121390024072685/0001213900-24-072685-index.htm","us_notice_code":"Form 425","us_title_en":"Form 425 - Prospectuses and communications, business combinations","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024072685/ea0212462-8k425_arcabio.htm","primary":true,"translateUrl":"","linkName":"ea0212462-8k425_arcabio.htm","type":"425","id":"NTFILEDXQ7v8S4sgF19LXX","market":"us","size":33735},{"description":"PRESS RELEASE, ISSUED ON AUGUST 26, 2024","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024072685/ea021246201ex99-1_arcabio.htm","primary":false,"translateUrl":"","linkName":"ea021246201ex99-1_arcabio.htm","type":"EX-99.1","id":"NTFILE5pvMTA3no6JFY1LQ","market":"us","size":18615}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"Business Combinations","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"Business Combinations","pubTime":"2024-08-27 12:00","pubTimestamp":1724731200,"title_zh":"Form 425 - Prospectuses and communications, business combinations","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18635280","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024072251-ORKA","pdf_url":"","pub_time":1724385600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ORKA","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/907654/000121390024072251/0001213900-24-072251-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE, ISSUED ON AUGUST 23, 2024","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024072251/ea021219701ex99-1_arcabio.htm","primary":true,"translateUrl":"","linkName":"ea021219701ex99-1_arcabio.htm","type":"EX-99.1","id":"NTFILE7rRvo48QumzoumLc","market":"us","size":21008},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024072251/ea021219701-8k_arcabio.htm","primary":false,"translateUrl":"","linkName":"ea021219701-8k_arcabio.htm","type":"8-K","id":"NTFILEF1MNyCNqjci7Msex","market":"us","size":67153}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2024-08-23 12:00","pubTimestamp":1724385600,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18635245","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024070263-ORKA","pdf_url":"","pub_time":1723780800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ORKA","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/907654/000121390024070263/0001213900-24-070263-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE, ISSUED ON AUGUST 16, 2024","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024070263/ea021161701ex99-1_arcabio.htm","primary":true,"translateUrl":"","linkName":"ea021161701ex99-1_arcabio.htm","type":"EX-99.1","id":"NTFILEGZceCi348pz99n5t","market":"us","size":22113},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024070263/ea0211617-8k425_arcabio.htm","primary":false,"translateUrl":"","linkName":"ea0211617-8k425_arcabio.htm","type":"8-K","id":"NTFILEGzworbHcQzmGxYLc","market":"us","size":51402}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2024-08-16 12:00","pubTimestamp":1723780800,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18635191","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024070266-ORKA","pdf_url":"","pub_time":1723780800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 425 - Prospectuses and communications, business combinations","symbol":"ORKA","title":"Form 425 - Prospectuses and communications, business combinations","titleType":"Business Combinations","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/907654/000121390024070266/0001213900-24-070266-index.htm","us_notice_code":"Form 425","us_title_en":"Form 425 - Prospectuses and communications, business combinations","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024070266/ea0211617-8k425_arcabio.htm","primary":true,"translateUrl":"","linkName":"ea0211617-8k425_arcabio.htm","type":"425","id":"NTFILE4f7z4PUNgUJckDvN","market":"us","size":46722},{"description":"PRESS RELEASE, ISSUED ON AUGUST 16, 2024","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024070266/ea021161701ex99-1_arcabio.htm","primary":false,"translateUrl":"","linkName":"ea021161701ex99-1_arcabio.htm","type":"EX-99.1","id":"NTFILEDatxCqSvbwzhT7jm","market":"us","size":22113}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"Business Combinations","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"Business Combinations","pubTime":"2024-08-16 12:00","pubTimestamp":1723780800,"title_zh":"Form 425 - Prospectuses and communications, business combinations","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18635210","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024069662-ORKA","pdf_url":"","pub_time":1723694400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ORKA","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/907654/000121390024069662/0001213900-24-069662-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ASSET PURCHASE AGREEMENT, DATED AUGUST 14, 2024, BY AND BETWEEN ARCA BIOPHARMA,","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024069662/ea021147201ex10-1_arcabio.htm","primary":true,"translateUrl":"","linkName":"ea021147201ex10-1_arcabio.htm","type":"EX-10.1","id":"NTFILEFB4BBZHogvCYLUGW","market":"us","size":57283},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024069662/ea0211472-8k425_arcabio.htm","primary":false,"translateUrl":"","linkName":"ea0211472-8k425_arcabio.htm","type":"8-K","id":"NTFILE5WjdFSvRDbxf9Y5Z","market":"us","size":53417}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2024-08-15 12:00","pubTimestamp":1723694400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18635203","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024069667-ORKA","pdf_url":"","pub_time":1723694400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 425 - Prospectuses and communications, business combinations","symbol":"ORKA","title":"Form 425 - Prospectuses and communications, business combinations","titleType":"Business Combinations","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/907654/000121390024069667/0001213900-24-069667-index.htm","us_notice_code":"Form 425","us_title_en":"Form 425 - Prospectuses and communications, business combinations","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024069667/ea0211472-8k425_arcabio.htm","primary":true,"translateUrl":"","linkName":"ea0211472-8k425_arcabio.htm","type":"425","id":"NTFILErky4Lb4Wp9CjNzvh","market":"us","size":48740},{"description":"ASSET PURCHASE AGREEMENT, DATED AUGUST 14, 2024, BY AND BETWEEN ARCA BIOPHARMA,","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024069667/ea021147201ex10-1_arcabio.htm","primary":false,"translateUrl":"","linkName":"ea021147201ex10-1_arcabio.htm","type":"EX-10.1","id":"NTFILEFrYvcUt4KNzwhiWV","market":"us","size":57283}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"Business Combinations","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"Business Combinations","pubTime":"2024-08-15 12:00","pubTimestamp":1723694400,"title_zh":"Form 425 - Prospectuses and communications, business combinations","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18635407","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024066829-ORKA","pdf_url":"","pub_time":1723176000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 425 - Prospectuses and communications, business combinations","symbol":"ORKA","title":"Form 425 - Prospectuses and communications, business combinations","titleType":"Business Combinations","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/0001213900-24-066829-index.htm","us_notice_code":"Form 425","us_title_en":"Form 425 - Prospectuses and communications, business combinations","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 425","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/ea0210924-425_arcabio.htm","primary":true,"translateUrl":"","linkName":"ea0210924-425_arcabio.htm","type":"425","id":"NTFILECoRgXFrRgyUVoXuT","market":"us","size":59437},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEA78FGU4CXtN7e4YR","market":"us","size":1140033},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_002.jpg","primary":false,"translateUrl":"","linkName":"image_002.jpg","type":"GRAPHIC","id":"NTFILE43fCSSB93DdScfUG","market":"us","size":1591196},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_003.jpg","primary":false,"translateUrl":"","linkName":"image_003.jpg","type":"GRAPHIC","id":"NTFILE4Y7kEnkEFhDRVFDb","market":"us","size":614792},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_004.jpg","primary":false,"translateUrl":"","linkName":"image_004.jpg","type":"GRAPHIC","id":"NTFILEJDx74YhUT3HEVh6i","market":"us","size":527288},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_005.jpg","primary":false,"translateUrl":"","linkName":"image_005.jpg","type":"GRAPHIC","id":"NTFILEFosMfCf1g7bzg1Ub","market":"us","size":371882},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_006.jpg","primary":false,"translateUrl":"","linkName":"image_006.jpg","type":"GRAPHIC","id":"NTFILE6zBjJ2dFYBt351ct","market":"us","size":584768},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_007.jpg","primary":false,"translateUrl":"","linkName":"image_007.jpg","type":"GRAPHIC","id":"NTFILEADXD9NLfiHtcoPHW","market":"us","size":379128},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_008.jpg","primary":false,"translateUrl":"","linkName":"image_008.jpg","type":"GRAPHIC","id":"NTFILEjEuys28uJUzS7C1H","market":"us","size":490476},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_009.jpg","primary":false,"translateUrl":"","linkName":"image_009.jpg","type":"GRAPHIC","id":"NTFILEGha7RzHuXAGu6UZs","market":"us","size":410367},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_010.jpg","primary":false,"translateUrl":"","linkName":"image_010.jpg","type":"GRAPHIC","id":"NTFILEFhy78QUg7gUY4zcK","market":"us","size":562910},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_011.jpg","primary":false,"translateUrl":"","linkName":"image_011.jpg","type":"GRAPHIC","id":"NTFILEbSXn12tHFhUNTT8e","market":"us","size":588926},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_012.jpg","primary":false,"translateUrl":"","linkName":"image_012.jpg","type":"GRAPHIC","id":"NTFILE3MA3K2ThLgEBowUR","market":"us","size":562585},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_013.jpg","primary":false,"translateUrl":"","linkName":"image_013.jpg","type":"GRAPHIC","id":"NTFILE2fZXqdXSiwPEPPpM","market":"us","size":680171},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_014.jpg","primary":false,"translateUrl":"","linkName":"image_014.jpg","type":"GRAPHIC","id":"NTFILEEhKthvZjBYcPoT5F","market":"us","size":555098},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_015.jpg","primary":false,"translateUrl":"","linkName":"image_015.jpg","type":"GRAPHIC","id":"NTFILECURn9JbzT7XjSeSr","market":"us","size":375213},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_016.jpg","primary":false,"translateUrl":"","linkName":"image_016.jpg","type":"GRAPHIC","id":"NTFILE9ynw5MPby3K1eBnW","market":"us","size":550981},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_017.jpg","primary":false,"translateUrl":"","linkName":"image_017.jpg","type":"GRAPHIC","id":"NTFILE5hToJDTzP3YEojWU","market":"us","size":562487},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_018.jpg","primary":false,"translateUrl":"","linkName":"image_018.jpg","type":"GRAPHIC","id":"NTFILE4J4RoF6rMgHb2mDR","market":"us","size":568752},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_019.jpg","primary":false,"translateUrl":"","linkName":"image_019.jpg","type":"GRAPHIC","id":"NTFILECKqsLBr5wSAs6bKH","market":"us","size":647921},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_020.jpg","primary":false,"translateUrl":"","linkName":"image_020.jpg","type":"GRAPHIC","id":"NTFILEGxH3d5tH2KPdLaTE","market":"us","size":543802},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_021.jpg","primary":false,"translateUrl":"","linkName":"image_021.jpg","type":"GRAPHIC","id":"NTFILEDrXagXzMhaEvK2Gj","market":"us","size":375600},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_022.jpg","primary":false,"translateUrl":"","linkName":"image_022.jpg","type":"GRAPHIC","id":"NTFILEDW5VX9SJN7fKYfvJ","market":"us","size":594651},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_023.jpg","primary":false,"translateUrl":"","linkName":"image_023.jpg","type":"GRAPHIC","id":"NTFILE3ypvsrf6QXPcd4E4","market":"us","size":539035},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_024.jpg","primary":false,"translateUrl":"","linkName":"image_024.jpg","type":"GRAPHIC","id":"NTFILE126fociYuT3dTfgP","market":"us","size":582829},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_025.jpg","primary":false,"translateUrl":"","linkName":"image_025.jpg","type":"GRAPHIC","id":"NTFILE8fFmN1vuWHp4nVBw","market":"us","size":575862},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_026.jpg","primary":false,"translateUrl":"","linkName":"image_026.jpg","type":"GRAPHIC","id":"NTFILEGdGeRiDuh4MraAaa","market":"us","size":295578},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_027.jpg","primary":false,"translateUrl":"","linkName":"image_027.jpg","type":"GRAPHIC","id":"NTFILEFCTMMyAP3Prm89kz","market":"us","size":399964},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_028.jpg","primary":false,"translateUrl":"","linkName":"image_028.jpg","type":"GRAPHIC","id":"NTFILE3RPLhMFQJxQBNgdR","market":"us","size":701657},{"description":"GRAPHIC","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_029.jpg","primary":false,"translateUrl":"","linkName":"image_029.jpg","type":"GRAPHIC","id":"NTFILE2UEh86s622EHJRXh","market":"us","size":607479},{"description":"GRAPHIC","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_030.jpg","primary":false,"translateUrl":"","linkName":"image_030.jpg","type":"GRAPHIC","id":"NTFILEC1t4bvpv1PMerm69","market":"us","size":1557827},{"description":"GRAPHIC","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024066829/image_031.jpg","primary":false,"translateUrl":"","linkName":"image_031.jpg","type":"GRAPHIC","id":"NTFILE12NVPuSFbVf9ri9n","market":"us","size":1025758}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"Business Combinations","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"Business Combinations","pubTime":"2024-08-09 12:00","pubTimestamp":1723176000,"title_zh":"Form 425 - Prospectuses and communications, business combinations","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18635281","market":"us","labels":[],"media":"sec.gov","original_id":"AN95017024089246-ORKA","pdf_url":"","pub_time":1722484800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"ORKA","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/907654/000095017024089246/0000950170-24-089246-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000095017024089246/abio-20240630.htm","primary":true,"translateUrl":"","linkName":"abio-20240630.htm","type":"10-Q","id":"NTFILEBGZAifPv7Q5TXqYo","market":"us","size":1337108},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000095017024089246/abio-ex31_1.htm","primary":false,"translateUrl":"","linkName":"abio-ex31_1.htm","type":"EX-31.1","id":"NTFILE2R2azt3GS4LsGnXa","market":"us","size":11455},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000095017024089246/abio-ex31_2.htm","primary":false,"translateUrl":"","linkName":"abio-ex31_2.htm","type":"EX-31.2","id":"NTFILEB3X2eA5fsG8xEW5n","market":"us","size":11323},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000095017024089246/abio-ex32_1.htm","primary":false,"translateUrl":"","linkName":"abio-ex32_1.htm","type":"EX-32.1","id":"NTFILEEZ3tFBc6CHuhZoUw","market":"us","size":13465}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2024-08-01 12:00","pubTimestamp":1722484800,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18635267","market":"us","labels":[],"media":"sec.gov","original_id":"AN95017024089337-ORKA","pdf_url":"","pub_time":1722484800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 425 - Prospectuses and communications, business combinations","symbol":"ORKA","title":"Form 425 - Prospectuses and communications, business combinations","titleType":"Business Combinations","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/907654/000095017024089337/0000950170-24-089337-index.htm","us_notice_code":"Form 425","us_title_en":"Form 425 - Prospectuses and communications, business combinations","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"425","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000095017024089337/abio-425-20240801.htm","primary":true,"translateUrl":"","linkName":"abio-425-20240801.htm","type":"425","id":"NTFILEE5kLRf9yLqSoJhwy","market":"us","size":140082},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000095017024089337/img114114981_0.jpg","primary":false,"translateUrl":"","linkName":"img114114981_0.jpg","type":"GRAPHIC","id":"NTFILEDjG1g79kc5GF8LZ3","market":"us","size":22708}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"Business Combinations","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"Business Combinations","pubTime":"2024-08-01 12:00","pubTimestamp":1722484800,"title_zh":"Form 425 - Prospectuses and communications, business combinations","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18635246","market":"us","labels":[],"media":"sec.gov","original_id":"AN95017024089329-ORKA","pdf_url":"","pub_time":1722484800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ORKA","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/907654/000095017024089329/0000950170-24-089329-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000095017024089329/abio-ex99_1.htm","primary":true,"translateUrl":"","linkName":"abio-ex99_1.htm","type":"EX-99.1","id":"NTFILECDiVCVfEriGFM5VG","market":"us","size":98261},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000095017024089329/abio-20240801.htm","primary":false,"translateUrl":"","linkName":"abio-20240801.htm","type":"8-K","id":"NTFILEHGGMpTQcmbMi8pUW","market":"us","size":47695},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000095017024089329/img123434494_0.jpg","primary":false,"translateUrl":"","linkName":"img123434494_0.jpg","type":"GRAPHIC","id":"NTFILEBNKLwmA1xCp8gygu","market":"us","size":24054}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2024-08-01 12:00","pubTimestamp":1722484800,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18635305","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024063687-ORKA","pdf_url":"","pub_time":1721707200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"ORKA","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/907654/000121390024063687/0001213900-24-063687-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000121390024063687/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEAg3cczU4cU9hdAwv","market":"us","size":5782}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2024-07-23 12:00","pubTimestamp":1721707200,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18635249","market":"us","labels":[],"media":"sec.gov","original_id":"AN101376224000532-ORKA","pdf_url":"","pub_time":1721620800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"ORKA","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/907654/000101376224000532/0001013762-24-000532-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000101376224000532/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEDLXCAJPCtK5YzA3j","market":"us","size":22073},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000101376224000532/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEFTK81UqwUVa2Ruyq","market":"us","size":9623},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/907654/000101376224000532/image_002.jpg","primary":false,"translateUrl":"","linkName":"image_002.jpg","type":"GRAPHIC","id":"NTFILEEA7Y8ZHUDNVwrYh2","market":"us","size":3409}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2024-07-22 12:00","pubTimestamp":1721620800,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":38,"code":"91000000","status":"200"}]}}